OMED: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 07/31/2014 settlement date, and OncoMed Pharmaceuticals Inc. (OMED) is one of the most shorted stocks of the Russell 3000, based on 19.07 "days to cover" versus the median component at 6.30. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then divided by the average daily volume, to express the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

In the case of OncoMed Pharmaceuticals Inc. ( OMED), the total short interest at the 07/31/2014 settlement date was 2,162,404 shares, which compares to the average daily trading volume of just 113,366 shares, for a "days to cover" ratio of 19.07.

When short sellers eventually cover their positions, by definition there must be buying activity because a share that is currently sold short must be purchased to be covered. At the present levels of short interest, if from this point forward every single OMED share traded represented a short position being closed, then at the average daily volume of 113,366 shares it would only be during the 20th trading day that every short position would be closed.

So it would stand to reason that should some unexpectedly good news come out, and short sellers did not have 20 days of patience but instead wanted to cover their short positions very suddenly, that situation could result in sending the stock higher until the higher price produces enough sellers to generate the necessary volume to close out those positions quickly.

OncoMed Pharmaceuticals Inc. ( OMED) has something relatively rare for a stock with this much short interest, that being insiders taking the other side of the trade. Looking back over the trailing six month period, OMED has seen 2 different instances of insider buying, as summarized by the table below:

Purchased Insider Title Shares Price/Share Value
08/15/2014 Jack W. Lasersohn Director 1,045 $17.00 $17,765.00
08/21/2014 Deepika Pakianathan Director 80,203 $18.98 $1,521,872.15

Below is a chart showing the "days to cover" for OMED over time:

Loading+chart++2014+TickerTech.com

And looking at the chart below, OMED's low point in its 52 week range is $12.07 per share, with $42.34 as the 52 week high point — that compares with a last trade of $20.06.

OncoMed Pharmaceuticals Inc. Moving Averages Chart

In recent trading, shares of OncoMed Pharmaceuticals Inc. ( OMED) were changing hands at $20.06/share.

More from Stocks

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Market Can't Handle the Wild Ride: Cramer's 'Mad Money' Recap (Thursday 5/24/18)

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Replay: Jim Cramer on North Korea, Oil Prices, Apple and Carnival Corporation

Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz

Canopy Growth: First Cannabis Firm on the NYSE Fails to Generate Buzz

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Video: This Startup Connects Buyers and Sellers of Legal Marijuana

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit